Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.22.1
Condensed Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 19,246 $ 24,534
Prepaids and other current assets 1,095 1,314
Short-term investments 135 219
Total current assets 20,476 26,067
Property and equipment, net 9 10
Total assets 20,485 26,077
Current liabilities:    
Accounts payable 1,579 1,584
Accrued expenses 1,419 1,733
Short-term loan 215 538
Total current liabilities 3,213 3,855
Warrant liabilities 0 0
Total liabilities 3,213 3,855
Commitments and contingencies (Note 4 and Note 9)
Stockholders' equity    
Preferred stock, par value $0.0001; 10,000,000 shares authorized as of March 31, 2022 and December 31, 2021; no shares issued and outstanding at March 31, 2022 and December 31, 2021. 0 0
Common stock, par value $0.0001; 75,000,000 shares authorized as of March 31, 2022 and December 31, 2021; 19,213,651 and 18,845,828 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively. 2 2
Additional paid-in capital 113,233 111,588
Accumulated deficit (95,963) (89,368)
Total stockholders' equity 17,272 22,222
Total liabilities and stockholders' equity $ 20,485 $ 26,077